Healthcare Global Enterprises Limited has informed the Exchange regarding Appointment of Bijou Kurien as Non- Executive Independent Director (Additional Director in terms of Section 161 of the Companies Act, 2013) for a period of 3 years, of the company w.e.f. Jun 30, 2025, subject to the shareholders approval.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises (HCG) has appointed Mr. Bijou Kurien as a Non-Executive Independent Director on its board, effective June 30, 2025, for a term of three years. The appointment is subject to shareholder approval. Mr. Kurien brings over 40 years of experience in consumer and retail sectors, having held senior roles at Hindustan Unilever, Titan (as COO), and Reliance Retail (as President & CEO). He is not related to any existing directors or promoters and is not debarred by SEBI. He currently serves as an Independent Director on other listed and unlisted company boards.
This is a routine governance update and is unlikely to move the stock significantly. The appointment adds a seasoned industry veteran from the consumer/retail world to the board, which could bring fresh strategic and brand-building perspectives to HCG, a healthcare company.